Generic Firms Get Supreme Shield From Product Liability, But Court Hints At Reg Change
This article was originally published in The Pink Sheet Daily
Executive Summary
In Pliva v. Mensing, the high court said it was impossible for generic manufacturers to comply with both state tort laws and FDA regulations requiring them to have the same labels as those for brand name counterparts.
You may also be interested in...
Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
California Supreme Court finds Novartis liable for alleged injuries from use of a generic version of Brethine even though they occurred six years after Novartis transferred the NDA; dissenting opinion says this will expose companies to "liability in perpetuity."
Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
California Supreme Court finds Novartis liable for alleged injuries from use of a generic version of Brethine even though they occurred six years after Novartis transferred the NDA; dissenting opinion says this will expose companies to "liability in perpetuity."
FDA Label Decisions On Paxil Don't Deter Verdict Against GSK In Suicide Case
Chicago jury finds GSK failed to adequately warn about risk of suicidal behavior in patients over age 24 taking paroxetine; GSK argued that FDA had found no increased risk in this population.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: